Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04953962
Title Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors CanBas Co. Ltd.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.